Drug Discovery

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.

It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"